Details for Patent: 10,576,156
✉ Email this page to a colleague
Which drugs does patent 10,576,156 protect, and when does it expire?
Patent 10,576,156 protects NEFFY and is included in one NDA.
This patent has seventy patent family members in twenty-eight countries.
Summary for Patent: 10,576,156
| Title: | Compositions for drug administration |
| Abstract: | The present invention provides compositions and methods and for increasing the bioavailability of therapeutic agents in a subject. The compositions include at least one alkyl glycoside and at least one therapeutic agent, wherein the alkylglycoside has an alkyl chain length from about 10 to about 16 carbon atoms. |
| Inventor(s): | Maggio Edward T. |
| Assignee: | Aegis Therapeutics, LLC |
| Application Number: | US15890131 |
|
Patent Claim Types: see list of patent claims |
Drugs Protected by US Patent 10,576,156
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ars Pharms Operation | NEFFY | epinephrine | SPRAY;NASAL | 214697-001 | Aug 9, 2024 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,576,156
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2009329952 | ⤷ Sign Up | |||
| Australia | 2011317202 | ⤷ Sign Up | |||
| Australia | 2019217643 | ⤷ Sign Up | |||
| Australia | 2021254650 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
